A patient with a mild hemolytic anemia and osmotically fragile, spherocytic erythrocytes was studied. Analysis of the erythrocyte membrane proteins by SDS-PAGE revealed a deficiency of protein 4.2 (less than 0.10% of normal). The protein 4.2-deficient erythrocytes contained normal amounts of all other membrane proteins, although the amount of band 3 was slightly reduced and the amount of band 6 (G3PD) was slightly elevated. The spectrin content of these cells was normal, as measured by both SDS-PAGE and radioimmunoassay. Erythrocytes from the patient's biologic parents were hematologically normal and contained normal amounts of protein 4.2. Immunological analysis using affinity purified antibodies revealed that the patient's protein 4.2 was composed of equal amounts of a 74-kD and 72-kD protein doublet, whereas the normal protein was composed primarily of a 72-kD monomer. Proteolytic digestion studies using trypsin, alpha-chymotrypsin and papain demonstrated that the patient's protein 4.2 was similar but not identical to the normal protein. Binding studies showed that the protein 4.2-deficient membranes bound purified protein 4.2 to the same extent as normal membranes, suggesting that the membrane binding site(s) for the protein were normal. Depleting the protein 4.2-deficient membranes of spectrin and actin resulted in a loss of nearly two-thirds of the membrane ankyrin, whereas similar depletion of normal membranes resulted in no loss of ankyrin. Repletion of the protein 4.
Introduction A major determinant of erythrocyte membrane shape and stability is the membrane cytoskeleton, a two-dimensional protein lattice located on the inner surface of the cell membrane. It is composed of two major supporting proteins, spectrin and actin; two linking proteins, ankyrin and protein 4.1; and their respective attachment sites on the cytoplasmic poles of band 3 and glycophorin (1) . Defects or deficiencies in the protein Dr. Schwartz' present address is Albert Einstein College of Medicine/ Montefiore Hospital Medical Center, Department of Hematology, Central 221, 11 1 East 210th Street, Bronx, NY 10467. Please address reprint requests to him.
Receivedfor publication 5 June 1987 and in revisedform 19 October 1987. composition of the membrane cytoskeleton, or in the proteins that link the cytoskeleton to the membrane bilayer, usually result in abnormal erythrocyte morphologies and mild to severe hemolytic anemias. Genetic mutations in spectrin and protein 4.1 have been reported (2) (3) (4) (5) and are associated with the hemolytic anemias hereditary spherocytosis (HS)' and hereditary elliptocytosis (HE). The present work examines a hematological disorder in which the erythrocytes are morphologically abnormal (spherocytic and elliptocytic), osmotically fragile and less deformable than normal erythrocytes. Unlike erythrocytes from patients with HS or HE, however, the protein abnormality observed in this patient's erythrocytes is a deficiency of protein 4.2.
Protein 4.2 is a 72-kD peripheral membrane protein which represents -5% of total membrane protein and is the last major erythrocyte membrane protein to remain uncharacterized. It is known to bind to the cytoplasmic pole of band 3 (6) , and crosslinking studies have suggested that it is probably a tetramer both on the membrane and in solution (7) . Other studies, in which membrane extracts containing band 3, protein 4.2 and ankyrin bound as a complex to an anti-ankyrin affinity column, suggested that these proteins may be associated in the membrane (8) .
In the current study, we have demonstrated that a protein 4.2 deficiency is associated with abnormalities in erythrocyte shape and membrane stability. Although the protein 4.2-deficient ghost membranes contained a normal amount of ankyrin, membrane vesicles produced by low ionic strength extraction contained less ankyrin than normal membranes indicating a weakened interaction of ankyrin with the spectrin-depleted protein 4.2-deficient membrane. This abnormal ankyrin-membrane interaction could be partially corrected by reconstituting purified protein 4.2 into the protein 4.2-deficient ghost membranes. We suggest that this abnormal ankyrin-membrane interaction in the protein 4.2-deficient erythrocytes may be responsible for some of the membrane defects observed at the cellular level.
Methods
Clinical studies. After obtaining informed consent, venous blood was drawn from the patient, the patient's biologic parents and normal control subjects. Routine hematological parameters were determined on an automated cell counter (Coulter model S Plus; Coulter Electronics, Hialeah, FL).
Reticulocyte counts were performed after new methylene blue staining (9) . Osmotic fragility studies were performed on heparinized blood after sterile incubation for 24 h at 370C by the method of Dacie (9) . Morphologic studies. Fixation oferythrocytes for study by scanning electron microscopy (SEM) was carried out by mixing anticoagulated whole blood with a 10-fold volume of 1% glutaraldehyde, 100 mM Na cacodylate, pH 7.4, for 2 h at 250C. After removal of the fixative, the cells were washed three times with 20 vol of50 mM Na cacodylate, 250 mM sucrose and added to 20 vol of 1% osmium tetroxide, 50 mM Na cacodylate, 212 mM sucrose for 2 h at 250C with gentle mixing. The fixed cells were then washed five times with 60 vol of distilled water (dH20), resuspended in 60 vol dH20, and stored at 4VC until scanned. For scanning, one drop offixed cells was applied to a microscope cover slip and allowed to settle for 1 h. Excess dH20 was removed with filter paper, the samples allowed to air dry, a thin film (20 nm) of gold was deposited on the surface of the cells and they were examined in an AMR-1OOOA scanning electron microscope at 10 kV.
Membrane deformability studies (osmotic gradient ektacytometry). Whole red cell deformability was measured as a continuous function of the suspending medium osmolality using an ektacytometer (Technicon Instruments, Tarrytown, NY) (10) . Cell deformability is expressed as a deformability index which is equivalent to the ellipticity of the deformed cells.
Membrane lipid analysis. Membrane lipid extraction was performed according to the method of Rose and Oklander (1 1). Cholesterol was determined according to Zlatkis et al. (12) and phospholipid was determined as inorganic phosphorus (13) .
Preparation oferythrocyte ghosts and membrane vesicles. Erythrocyte ghosts were prepared from freshly drawn blood anticoagulated in acid citrate/dextrose by the hypotonic lysis procedure of Dodge et al. (14) except that 0.4 mM diisopropylfluorophosphate (DFP) was added at the lysis step. Spectrin and actin depleted inside-out vesicles (IOVs) were prepared by the method of Bennett and Branton (15) , with some modifications; ghost membranes were incubated in 0.1 mM Tris/HCl, pH 8.0, at 37°C for 30 min to induce membrane vesiculation. Protein 4.1and ankyrin-depleted IOVs were prepared by the method of Hargreaves et al. ( 16) . Preparation ofantiserum. Monospecific antibodies against human erythrocyte spectrin were purchased from Miles Laboratories (Naperville, IL). Anti-ankyrin IgG was made by immunizing rabbits with human erythrocyte ankyrin purified by the method of Tyler et al. (17) . Anti-protein 4.2 IgG was made by electroeluting protein 4.2 from polyacrylamide gels on which proteins from pH 11.0 extracts of IOVs were separated, and then immunizing rabbits with the electroeluted protein by standard immunization techniques. The anti-protein 4.2 IgG was affinity purified on Affi-gel 10 (Bio-Rad Laboratories, Richmond, CA) that had been coupled to erythrocyte membrane pH 11.0 extracts.
Gel electrophoresis and immunoblotting. SDS-PAGE was performed utilizing either the discontinuous buffer system of Laemmli (18) , or when ankyrin was to be quantitated, the continuous buffer system of Fairbanks et al. (19) . The proteins were stained with Coomassie Brilliant Blue, and after destaining the gels were scanned using a laser densitometer (LKB model 2222; LKB Instruments, Inc., Gaithersburg, MD) with GSXL/1D software. For immunoblotting purposes, the proteins were transferred to nitrocellulose according to the procedure ofTowbin et al. (20) and the immunoblots developed with horseradish peroxidase (HRP)-conjugated second antibody and HRP substrate (Bio-Rad Laboratories).
Limited proteolytic digestion of vesicle membranes. Normal and patient spectrin-depleted IOV membranes were prepared as described above (15) . Vesicle membranes (150 ,ug) were then incubated with 1 ,ug trypsin, I ,ug a-chymotrypsin or 0.33 Mg papain (total volume 0.1 ml) for 1 h at 4°C. The reaction was terminated by the addition of the Laemmli solubilization buffer (18) and boiling for 2 min. Aliquots were then analyzed by SDS-PAGE (7.5 Mg normal, 150 Mg patient) and immunoblotting using anti-protein 4 (21) , with some modifications. Spectrin-depleted IOVs were prepared by incubating ghost membranes in 30 vol of0.1 mM EGTA, pH 8.5, at 370C for 30 min. Ankyrin, protein 4.1 and glyceraldehyde-3-phosphate dehydrogenase (G3PD) were extracted from IOVs by incubation in 1 M KC1 at 370C for 30 min, and protein 4.2 along with any residual ankyrin and protein 4.1 was extracted by incubation in 0.1 mM EDTA, pH 11.0, for 45 min at 370C.
To purify protein 4.2, the pH 11.0 extract, immediately neutralized to pH 8.0, was applied to a Sephacryl S-200 gel filtration column (2.5 X 65 cm) equilibrated in 5 mM sodium phosphate, pH 8.0, containing 1 M potassium iodide, 0.5 mM EGTA, and 0.5 mM DTT. For reassociation studies, purified protein 4.2 was radioiodinated using the Bolton Hunter Reagent (22) .
Preparation ofprotein 4.2-depleted IO Vs. Protein 4.2-depleted IOV membranes were prepared by adding the 1 M KCI extracted membranes described above to 30 vol of 0.1 mM EGTA, pH 11.0 and incubating at 370C for 45 min. The protein 4.2-depleted IOVs were collected by centrifugation, immediately brought to pH 8.0, and then dialyzed vs. 5 mM sodium phosphate, 0.1 mM EGTA, pH 8.0, as described by Korsgren and Cohen (21) . Protein 4.2 membrane binding assay. Binding of '25I-protein 4.2 to pH 11.0 stripped (protein 4.2-depleted) IOVs was measured according to the method of Korsgren and Cohen (21) , with some modifications. The pH 11.0 stripped IOVs had < 10% of the normal amount of protein 4.2 and were essentially composed of only band 3. In our hands, we found that a considerable amount of nonspecific binding of purified protein 4.2 to tube surfaces occurred (65% of total binding), therefore, the iodinated protein 4.2 was routinely precentrifuged at 40,000 g for 30 min at 4°C immediately before use in the binding assay. This pre-spin resulted in < 10% nonspecific protein binding. The protein concentration ofpH 11.0 stripped IOVs was often variable by dye binding protein determinations, therefore, IOVs were solubilized in 1% SDS and protein measured at 280 nm. Various concentrations of purified protein 4.2 (0-140 ug/ml) were incubated in duplicate with pH 11.0 stripped IOVs (20 Mug) in 120 mM KC1, 5 mM sodium phosphate, pH 8.0, 0.5 mM EGTA, 0.5 mM DTT, 1 mg/ml BSA, 0.02% NaN3 (reassociation buffer) in a total volume of 0.2 ml for 18 h at 4°C. The mixtures were then centrifuged in a 42.2 Ti rotor at 20,000 rpm for 30 min at 4°C in an ultracentrifuge (model L8-80; Beckman Industries, Palo Alto, CA). After removal ofthe supernatants, the IOVs were washed once in reassociation buffer and counted. Control experiments without IOVs were similarly performed for each protein 4.2 concentration tested and nonspecific binding of protein 4.2 was subtracted from the experimental values. Duplicate values varied by no more than 5%. Binding curves were additionally analyzed by the method of Scatchard (23) . Preparation ofprotein 4.2-reassociated erythrocyte membranes. Erythrocyte ghost membranes and protein 4.2, prepared as described above, were equilibrated in 5 mM sodium phosphate, pH 8.0. Leaky ghost membranes (165 Mg) were incubated with purified protein 4.2 (35 MAg) in a total volume of 1.0 ml 5 mM sodium phosphate, pH 8.0, 0.5 mM EGTA, 0.5 mM DTT, 0.02% NaN3, and 1 ,g/ml leupeptin, for 3 h at 4°C. At the end of 3 h, 120 mM KCl was added to induce ghost resealing and protein 4.2 binding (21) and the incubation continued for an additional 15 h at 4°C. At the end of the incubation, the ghosts were collected by centrifugation, washed, and spectrin-depleted IOVs prepared from the resealed ghosts, as described above.
Results
Morphological and clinical studies. The patient is a 26-yr-old Japanese-American female who was followed over a period of 2 yr. She presented with a mild Coombs negative hemolytic anemia (Hgb 10.9 g/dl, 8% reticulocytes) with most of the erythrocytes exhibiting a spherocytic shape along with 5-10% elliptocytes (Table I and Fig. 1 ). Erythrocyte osmotic fragility was increased (50% of the cells lysed at 0.65-0.67% NaCl compared with 0.5% NaCl for normal cells). Erythrocytes from the patient's biologic parents were also tested and all hematological parameters were normal. The patient was splenectomized -6 mo after our initial studies were performed that corrected the anemia (Hgb 12.7 g/dl, reticulocytes < 1%) although the abnormal erythrocyte morphology and osmotic fragility persisted.
Patient erythrocyte membranes are less deformable. The membrane deformability profile as measured by ektacytometry was abnormal in the patient as compared to controls (Fig.  2) . The reduction in the maximally attained deformability index (maximal height of the curve) is indicative of a reduced membrane surface area, and the shift to the right of the deformability minimum in the hypotonic range (100-200 mosmol/kg) is indicative ofa reduced surface area to volume ratio. This pattern is similar to those observed with erythrocytes from patients with iron deficiency or mild HS. The patient in our study was not found to be iron deficient (free erythrocyte protoporphyrin was 59 g/dl). Patients with typical HS whose erythrocytes are dehydrated usually show an altered profile in the hypertonic range of the ektacytometer scan, whereas the patient in our study was normal in this regard. The ektacytometric scans of the patient's parents were normal.
The loss of membrane surface area in the patient's erythrocytes indicated by the ektacytometric scans was confirmed by direct lipid measurements (Table II) . Both the cholesterol and phospholipid content of the patient's erythrocytes were below normal (3.4 mM and 4.0 mM, respectively), and the cholesterol/phospholipid ratio (C/PL ratio) was slightly decreased (C/PL = 0.86) due to a relative smaller cholesterol content compared to phospholipid content. The decreased C/PL ratio of the patient's erythrocytes persisted postsplenectomy (C/PL = 0.85).
Protein composition of patient erythrocyte membranes. Analysis of patient ghost membrane proteins by SDS-PAGE revealed that the patient membranes were > 90% deficient in protein 4.2 ( Fig. 3 and Table III ). This is not the result of * All values except FEP and reticulocytes were from the Coulter excessive proteolysis of the membrane proteins during handling since both patient and normal blood samples were drawn at the same time and handled identically. We were also careful to use chilled buffers and include protease inhibitors during all preparative procedures. In addition to the absence of protein 4.2, the patient's membranes had a statistically significant decrease in the amount of band 3 and an elevated amount of band 6 (G3PD). The deficiency of protein 4.2, decreased content of band 3 and increased content of band 6 persisted postsplenectomy. To rule out the possibility that the abnormal cell morphology, osmotic fragility and deformability of the patient's erythrocytes was due to a small decrease in the amount ofspectrin that might not be detected by electrophoretic analysis, total erythrocyte spectrin was measured by radioimmunoassay, as described by Agre et al. (2) . As shown in Fig. 4 , the patient's erythrocytes had normal amounts of spectrin. Electrophoretic analysis of erythrocyte ghost membranes from both of the patient's biologic parents revealed a normal content of all membrane proteins (data not shown).
To rule out the possibility that the patient's erythrocytes contained protein 4.2 in the cell cytosol instead of attached to the membrane, we solubilized whole erythrocytes in 5% SDS and analyzed the solubilized proteins by SDS-PAGE. Whereas protein 4.2 was detected in normal solubilized erythrocytes, we did not detect protein 4.2 in the patient's solubilized erythrocytes (data not shown).
Patient erythrocyte membranes contain a small amount of immunoreactive protein 4.2. When SDS-PAGE-separated patient ghost membranes were further analyzed by immunoblotting with affinity purified anti-protein 4.2 IgG, a small amount of an immunoreactive protein 4.2 analogue was observed (< 10% ofnormal protein 4.2). This protein 4.2 variant differed from the normal protein in that it was composed of equal amounts of a protein doublet (74 and 72 kD), whereas the normal protein was composed primarily of a single molecular species of 72 kD (Fig. 5 ). The binding ofthe protein 4.2 variant to its membrane binding site(s) appeared to be normal since it could only be removed from the membrane by using relatively harsh conditions (pH 11.0), similar to the case for the normal protein.
Limited proteolytic digestion patterns of normal and patient protein 4.2 are similar but not identical. To determine if the patient's protein 4.2 variant was molecularly similar to the normal protein, IOVs prepared from patient and normal erythrocytes were partially digested with proteases (trypsin, a-chymotrypsin, and papain) and the peptides generated were analyzed by SDS-PAGE combined with immunoblotting using anti-protein 4.2 IgG (Fig. 6 ). Using these three proteases, patient protein 4.2 digests contained most ofthe protein bands corresponding to the major bands in the normal digests. However, some differences were apparent, most notably in the achymotrypsin and papain digests where the normal digests contained at least one major protein band not seen in the patient digests. Furthermore, many of the protein bands in the patient digests were doublets, which were most likely related to the protein doublet observed in the undigested patient protein.
These results suggest that the normal protein and patient protein 4.2 variant are structurally related but not identical proteins. OSMOLALITY (MOSMOL/KG) Figure 2 . Osmotic gradient ektacytometric scans of normal and patient erythrocytes. The deformability index (DI) was measured at a constant applied shear stress as a continuous function of the suspending medium osmolality (mosmol/kg). The shaded area represents the normal range. In the patient, the curve minimum is shifted to the right and the maximum DI is decreased indicating an increase in osmotic fragility and a loss of membrane surface area.
membrane binding site for protein 4.2 in the patient membranes, normal and patient pH 11.0 extracted (protein 4.2stripped) IOVs were reassociated with purified normal protein 4.2. The amount of protein 4.2 rebinding was similar, indicating that the patient's membranes had a normal complement of protein 4.2 binding sites ( Fig. 7 A) . Scatchard analysis of the rebinding data indicated that both normal and patient membranes had a maximal protein 4.2 binding capacity of 180 ug/mg band 3 that is equivalent to 1 protein 4.2 monomer/4 band 3 monomers ( Fig. 7 B) . This calculated stoichiometry is similar to the ratio of protein 4.2 to band 3 measured in erythrocyte membranes (1 protein 4.2 monomer/3.9 band 3 monomers) (24) . Decreased association of ankyrin with the membrane in spectrin-depleted patient IO Vs. When spectrin and actin were extracted from the protein 4.2-deficient ghost membranes, most of the ankyrin was also lost from the membrane and recovered in the low ionic strength supernatant. By contrast, in normal membranes ankyrin is completely retained on the membrane under these conditions (Fig. 8 ). Since a normal amount of ankyrin is present on the patient ghost membranes this suggests that only under conditions that remove spectnn and actin does the ankyrin-membrane interaction become un- stable in the patient's membranes. To determine if a decrease in the number of ankyrin membrane binding sites was responsible for the loss of ankyrin from the patient IOVs, normal purified ankyrin was reassociated with normal and patient ankyrin-stripped IOVs. Similar ankyrin binding was obtained using either IOVs suggesting that the number of ankyrin bind- ing sites on the patient's membranes is normal (data not shown).
Effect of rebinding protein 4.2 to protein 4.2-deficient membranes on ankyrin extractability. Normal and patient leaky ghost membranes were incubated with purified protein 4.2 and then resealed before preparing spectrin-depleted IOVs. Whereas approximately two-thirds of the ankyrin was extracted from the patient IOVs (but none from the normal IOVs), the reassociation of protein 4.2 with these membranes restored ankyrin binding to 80% of control levels (Table   IV) . These results strongly suggest that protein 4.2 plays an important functional role in stabilizing ankyrin on the erythrocyte membrane. We found that the amount of protein 4.2 that could bind to either the normal or protein 4.2-deficient leaky ghost membranes was considerably greater than that normally found in the native membrane ( Fig. 9) , possibly reflecting binding to low affinity sites reported by Korsgren and Cohen (2 1).
Discussion
The identification of pathologic erythrocytes that are deficient in specific membrane proteins, or whose membranes contain functionally abnormal proteins, has been a valuable tool in the elucidation of protein structural/functional roles. For example, certain forms of hemolytic anemias such as hereditary spherocytosis (HS), hereditary elliptocytosis (HE), and hereditary pyropoikilocytosis (HPP) have been shown to be related to the deficiency or abnormal function of specific membrane proteins (2) (3) (4) (5) 25) . In the present study, a patient with hemolytic anemia was identified whose erythrocytes were > 90% deficient of protein 4.2. Since little is known regarding the function of protein 4.2, we investigated the membrane properties of these protein 4.2-deficient membranes to determine if any structural/functional abnormalities resulted from the absence of this protein. Several investigators have reported that protein 4.2 was absent or reduced in certain cases of HS (26, 27) . However, no correlation was found between the degree of protein 4.2 deficiency and the severity of the disease. The patient described in this study presented with a mild Coombs negative hemolytic anemia with an abnormal erythrocyte morphology (spherocytic and elliptocytic shaped cells), increased osmotic fragility and decreased membrane deformability. Each of these criteria by themselves is consistent with a diagnosis ofHS, however, in contrast to typical HS, where a decrease in the amount of spectrin is usually found, the patient's erythrocytes had a normal amount of spectrin as determined both by electrophoretic analysis and by RIA. Furthermore, SDS-PAGE analysis of the patient's membranes revealed that only protein 4.2 was missing from the membrane. The small but statistically significant reduction in band 3 probably reflects a loss of membrane surface area due to vesiculation, and is consistent with the abnormal osmotic fragility and deformability of these membranes. The reason for the increased amount of band 6 is not clear at this time.
In addition to an abnormal cell morphology, cholesterol/ phospholipid ratio, and osmotic fragility that persisted in the patient's erythrocytes postsplenectomy, the deficiency of protein 4.2 in these cells also remained postsplenectomy. This is different from some other cases of protein 4.2 deficiency that have been reported where the missing protein reappeared after correction of the primary pathology. For example, in erythrocytes from patients with obstructive jaundice where a partial deficiency of protein 4.2 was reported, the erythrocyte content of the protein was found to be normal following surgical removal of the obstruction (28).
Erythrocytes from the patient's parents were found to be normal in the content of protein 4.2 as well as by all other criteria measured in our studies. Since we have not yet been able to study erythrocytes of the patient's siblings we do not know whether this defect was inherited or represented some other acquired abnormality such as a point mutation in the protein 4.2 gene or a defect in some as yet unidentified processing enzyme required for protein 4.2 biogenesis. Further studies are in progress to examine the etiology of the protein 4.2 deficiency in this patient.
When immunoblots of the patient's erythrocyte membranes were probed with an affinity purified antibody against normal protein 4.2, we found that the membranes contained a small amount of a protein 4.2 immunolog (< 10% of normal protein 4.2). This immunolog varied from the normal protein in that it was composed of equal amounts of a 74-and 72-kD protein doublet, whereas the normal protein was composed predominantly of a 72-kD monomer. The protein 4.2 immunolog appeared to be structurally similar to the normal protein since both proteins had similar proteolytic digestion patterns using trypsin, a-chymotrypsin, and papain. However, the protein 4.2 immunolog is not structurally identical to the normal protein since the a-chymotrypsin and papain digests of the normal protein contained at least one major protein band not seen in the protein 4.2 immunolog digests. The protein 4.2 immunolog appeared to associate with the erythrocyte membrane normally since it was extracted from the membrane only under harsh conditions (pH 11.0), similar to the normal protein. Preliminary experiments in our laboratory suggest that a protein 4.2 immunolog similar to the one in the patient's erythrocytes is also found in the patient's leukocytes, and is present in reduced amounts compared to normal leukocytes.
Clues as to a possible function of protein 4.2 came from studies examining the association of ankyrin with spectrin-depleted IOV membranes. Whereas in normal membranes the extraction of spectrin and actin by low ionic strength buffers does not result in a loss of ankyrin, in the protein 4.2-deficient membranes -70% of the ankyrin was extracted by low ionic strength buffer. Furthermore, reassociation of purified protein 4.2 to the protein 4.2-deficient membranes partially prevented the extraction of ankyrin at low ionic strength. These results suggest that one function ofprotein 4.2 is to stabilize or modulate interactions of ankyrin with its high affinity binding site on the membrane. That a large amount of added protein was required to generate this effect would suggest that not all ofthe reconstituted protein was assembled properly into the preassembled membrane cytoskeletons. This may be due to an inaccessibility of all of the added protein for its high affinity membrane binding sites. Other investigators have reported that protein 4.2 is not necessary for the reassociation of purified ankyrin to ankyrin-stripped membranes (16, 29) . The data presented in this study differs from these other studies in that we evaluated the loss of ankyrin from membranes and not the reassociation of purified ankyrin with ankyrin-stripped membranes. The procedures used to dissociate ankyrin from the membrane may affect the ankyrin binding site and/or alterations in ankyrin induced by its purification may also affect its membrane rebinding properties. Since a normal amount of ankyrin is present in the protein 4.2-deficient ghost membranes, this suggests that the ankyrin binding site is normal in these membranes. We hypothesize that the interaction of ankyrin with its high affinity membrane binding site on band 3 is weakened in the absence of protein 4.2, and in the absence of stabilizing interactions with spectrin and actin, the ankyrin dissociates from the membrane. Further studies will be necessary to determine the molecular basis for the apparent stabilizing effect of protein 4.2 on ankyrin-band 3 interactions.
In summary, we have identified and characterized a Coombs negative hemolytic anemia associated with a > 90% deficiency of protein 4.2. These erythrocytes are morphologically abnormal and mechanically unstable. They exhibit many of the same characteristics as typical HS erythrocytes except that the spectrin content of the protein 4.2-deficient cells is normal. Although splenectomy corrected the patient's anemia, the deficiency of protein 4.2 persisted as did the abnormal erythrocyte morphology, osmotic fragility and membrane mechanical properties. This would suggest that the absence of protein 4.2 somehow led to a membrane abnormality that was recognized by the spleen that removed these cells from the circulation. The precise molecular relationship between the deficiency of protein 4.2 and the membrane abnormality/hemolytic anemia remains unclear. That ankyrin may be involved is suggested by the decreased affinity of ankyrin for its membrane attachment site in the protein 4.2-deficient spectrin-depleted membranes, which was partially corrected by repletion of these membranes with purified protein 4.2. Further studies are needed to determine whether the protein 4.2 deficiency and the anemia are causally related, and to determine whether the molecular properties of the protein 4.2 variant observed in the protein 4.2-deficient membranes differ functionally from the normal protein. It should be noted that Hayashi et al. (26) observed the complete absence of protein 4.2 in 4 of 15 cases of HS they studied, and a decreased amount of the protein in all of the other cases. This suggests that protein 4.2 deficiency may not be a rare pathology, and further suggests that the absence or deficiency of this protein may be a component in the molecular mechanisms underlying some forms of HS.
